DNB Teknologi vs UBS Lux Equity Fund Biotech USD

DNB Teknologi vs UBS Lux Equity Fund Biotech USD

1. DNB Teknologi

  • Security

    DNB Teknologi A

  • Fee

    1.14%

  • ISIN

    NO0010337678

  • Holdings

    22

  • Number of owning funds

    1

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    9

Fund Holdings

We have information about 33 holdings in DNB Teknologi, where the largest holding is Microsoft (9.64), followed by Alphabet (7.17) and Meta (4.35). In comparison with UBS Lux Equity Fund Biotech USD, we have 11 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Moderna (9.21) and Vertex (8.44).

All Holdings

Here we compare the holdings in DNB Teknologi and UBS Lux Equity Fund Biotech USD.

DNB Teknologi UBS Lux Equity Fund Biotech USD
1. Microsoft Corp
USA
9.64 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Alphabet Inc Class A
USA
7.17 %
2. Moderna Inc
9.21 %
3. Meta Platforms A
USA
4.35 %
3. Vertex Pharmaceuticals Inc
8.44 %
4. Nvidia Corp
USA
4.25 %
4. Alnylam Pharmaceuticals Inc
8.08 %
5. Amazon.com Inc
USA
4.1 %
5. AbbVie Inc
USA
4.91 %
6. Nokia Oyj
4.1 %
6. Gilead Sciences Inc
USA
4.66 %
7. Ericsson B
Sweden
3.19 %
7. Amgen Inc
USA
4.43 %
8. Oracle Corp
2.99 %
8. BioNTech SE
4.13 %
9. SAP SE
Germany
2.47 %
9. Karuna Therapeutics Inc
3.75 %
10. SK Hynix Inc
South Korea
2.35 %
-
11. Visa Inc
USA
2.28 %
-
12. Mastercard Inc
USA
2.19 %
-
13. Western Digital Technologies Inc
USA
2.19 %
-
14. Apple Inc
USA
2.06 %
-
15. Datadog Inc
USA
2.01 %
-
16. Sandisk Corp
USA
1.91 %
-
17. Lam Research Corp
USA
1.76 %
-
18. ASML Holding NV
Netherlands
1.53 %
-
19. Broadcom Inc
USA
1.48 %
-
20. Samsung Electronics Co Ltd
South Korea
1.35 %
-
21. Embracer Group B
Sweden
1.35 %
-
22. Nordic Semiconductor ASA
Norway
1.3 %
-

The list of fund holdings was last updated on July 27, 2025.